-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 31, 2022, the international academic journal PNAS published online the latest research results of Hu Guohong's research group from Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, entitled "miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression", which clarified Novel regulatory mechanism and targeted therapy strategy of tumor-associated macrophages in breast cancer
.
Globally, breast cancer is the most common malignant tumor in women and one of the most lethal types of malignant tumors
.
Immune cells in the tumor microenvironment play a crucial role in cancers such as breast cancer
Graduate students Ma Chengxin, He Dasa, Tian Pu, etc.
, under the guidance of researcher Hu Guohong, found that breast cancer cells induce the high expression of miR-182 in macrophages through the TGFβ signaling pathway, and miR-182 directly inhibits the expression of the downstream TLR4 gene to cause macrophages.
The inactivation of the NFκb signaling pathway in cells in turn causes the polarization of macrophages to the pro-tumor M2 phenotype, which ultimately promotes the occurrence and development of breast cancer
.
More importantly, they also found that the use of cationized mannan-modified extracellular vesicles in multiple breast cancer models could target delivery of the miR-182 inhibitor antagomiR-182 to tumor macrophages efficiently.
In conclusion, this study revealed the important role of the TGFβ/miR-182/TLR4 signaling axis on tumor-associated macrophage polarization, and provided a rationale and strategy for RNA-based macrophage-targeted therapy
.
Researcher Hu Guohong from Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences is the corresponding author of the paper, and doctoral student Ma Chengxin is the first author
.
This work was supported by the cooperation and support of Professor Jin Zibing from Tongren Hospital Affiliated to Beijing Medical University and Researcher Ying Hao from Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences
Article link: https:// note: The functional mechanism and targeting strategy of miR-182 in regulating abnormal polarization of tumor-associated macrophages